Quarterly report pursuant to Section 13 or 15(d)

Subsequent Event (Tables)

Subsequent Event (Tables)

6 Months Ended

Jun. 30, 2018

The following table sets forth the Company’s Total Shareholders’ Equity position as of June 30, 2018, as adjusted on a pro forma basis to reflect the recently completed underwritten Public Offering:

Oragenics, Inc.

Pro Forma Shareholder’s Equity

(U.S. dollars)


Total Shareholders’ Equity as of June 30, 2018	$	3,650,580
Net Proceeds from July 17, 2018 Public Offering		12,300,000

Pro forma Total Shareholders’ Equity, as of June 30, 2018, as adjusted	$	15,950,580